| Signatures of copy number alterations in human cancer CD Steele, A Abbasi, SMA Islam, AL Bowes, A Khandekar, K Haase, ... Nature 606 (7916), 984-991, 2022 | 325 | 2022 |
| Uncovering novel mutational signatures by de novo extraction with SigProfilerExtractor SMA Islam, M Díaz-Gay, Y Wu, M Barnes, R Vangara, EN Bergstrom, ... Cell genomics 2 (11), 2022 | 243 | 2022 |
| Therapy-induced APOBEC3A drives evolution of persistent cancer cells H Isozaki, R Sakhtemani, A Abbasi, N Nikpour, M Stanzione, S Oh, ... Nature 620 (7973), 393-401, 2023 | 71 | 2023 |
| Chromosomal fragile site breakage by EBV-encoded EBNA1 at clustered repeats JSZ Li, A Abbasi, DH Kim, SM Lippman, LB Alexandrov, DW Cleveland Nature 616 (7957), 504-509, 2023 | 41 | 2023 |
| Significance and limitations of the use of next-generation sequencing technologies for detecting mutational signatures A Abbasi, LB Alexandrov DNA repair 107, 103200, 2021 | 30 | 2021 |
| APOBEC3A drives acquired resistance to targeted therapies in non-small cell lung cancer H Isozaki, A Abbasi, N Nikpour, A Langenbucher, W Su, M Stanzione, ... BioRxiv, 2021.01. 20.426852, 2021 | 20 | 2021 |
| Visualizing and exploring patterns of large mutational events with SigProfilerMatrixGenerator A Khandekar, R Vangara, M Barnes, M Díaz-Gay, A Abbasi, ... BMC genomics 24 (1), 469, 2023 | 11 | 2023 |
| Deep learning artificial intelligence predicts homologous recombination deficiency and platinum response from histologic slides EN Bergstrom, A Abbasi, M Díaz-Gay, L Galland, S Ladoire, SM Lippman, ... Journal of Clinical Oncology 42 (30), 3550-3560, 2024 | 10 | 2024 |
| Deep learning predicts HRD and platinum response from histology slides in breast and ovarian cancer EN Bergstrom, A Abbasi, M Díaz-Gay, L Galland, SM Lippman, S Ladoire, ... medRxiv, 2023.02. 23.23285869, 2023 | 5 | 2023 |
| The Complexity of Tobacco Smoke-Induced Mutagenesis in Head and Neck Cancer L Torrens, S Moody, AC de Carvalho, M Kazachkova, B Abedi-Ardekani, ... medRxiv, 2024.04. 15.24305006, 2024 | 2 | 2024 |
| Detecting HRD in whole-genome and whole-exome sequenced breast and ovarian cancers A Abbasi, CD Steele, EN Bergstrom, A Khandekar, A Farswan, RR Mckay, ... medRxiv, 2024 | 1 | 2024 |
| Unwinding the mutational signatures of a DNA topoisomerase enzyme A Abbasi, LB Alexandrov Nature 602 (7898), 580-581, 2022 | 1 | 2022 |
| Abstract LB391: Deep learning AI predicts HRD and platinum response from histologic slides EN Bergstrom, A Abbasi, M Diaz-Gay, L Galland, S Ladoire, SM Lippman, ... Cancer Research 84 (7_Supplement), LB391-LB391, 2024 | | 2024 |
| Abstract LB374: The microbial landscape of colorectal cancer across 11 countries A Abbasi, L Alexandrov Cancer Research 84 (7_Supplement), LB374-LB374, 2024 | | 2024 |
| Impact of therapy induced APOBEC3A mutagenesis on tumor evolution in non small cell lung cancer H Isozaki, A Abbasi, N Nikpour, M Stanzione, R Sakhtemani, SL Monroe, ... Cancer Research 82 (12_Supplement), 657-657, 2022 | | 2022 |
| Words of Wisdom EN Bergstrom, A Abbasi, M Díaz-Gay | | |
Ludmil B. AlexandrovProfessor, University of California San DiegoVerified email at ucsd.edu